These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 20050764

  • 1. Gabapentin vs. low-dose transdermal estradiol for treating post-menopausal women with moderate to very severe hot flushes.
    Aguirre W, Chedraui P, Mendoza J, Ruilova I.
    Gynecol Endocrinol; 2010 May; 26(5):333-7. PubMed ID: 20050764
    [Abstract] [Full Text] [Related]

  • 2. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 3. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.
    Reddy SY, Warner H, Guttuso T, Messing S, DiGrazio W, Thornburg L, Guzick DS.
    Obstet Gynecol; 2006 Jul; 108(1):41-8. PubMed ID: 16816054
    [Abstract] [Full Text] [Related]

  • 4. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS.
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [Abstract] [Full Text] [Related]

  • 5. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E.
    Biglia N, Sgandurra P, Peano E, Marenco D, Moggio G, Bounous V, Tomasi Cont N, Ponzone R, Sismondi P.
    Climacteric; 2009 Aug; 12(4):310-8. PubMed ID: 19415540
    [Abstract] [Full Text] [Related]

  • 6. Use of gabapentin in patients experiencing hot flashes.
    Brown JN, Wright BR.
    Pharmacotherapy; 2009 Jan; 29(1):74-81. PubMed ID: 19113798
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 8. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 May; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 9. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE, Koltun WD, Pascual ML, Day WW, Peterson C.
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [Abstract] [Full Text] [Related]

  • 10. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
    Archer DF, Pickar JH, MacAllister DC, Warren MP.
    Menopause; 2012 Jun; 19(6):622-9. PubMed ID: 22282101
    [Abstract] [Full Text] [Related]

  • 11. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C, Yu SL, Hiemeyer F, Schaefers M.
    Climacteric; 2009 Oct; 12(5):419-26. PubMed ID: 19479489
    [Abstract] [Full Text] [Related]

  • 12. Use of gabapentin for the management of natural or surgical menopausal hot flashes.
    Hayes LP, Carroll DG, Kelley KW.
    Ann Pharmacother; 2011 Mar; 45(3):388-94. PubMed ID: 21343402
    [Abstract] [Full Text] [Related]

  • 13. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [Abstract] [Full Text] [Related]

  • 14. Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause.
    Pinkerton JV, Kagan R, Portman D, Sathyanarayana R, Sweeney M, Breeze 3 Investigators.
    Menopause; 2014 Jun; 21(6):567-73. PubMed ID: 24149930
    [Abstract] [Full Text] [Related]

  • 15. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S, Ylikorkala O, Arrenbrecht S.
    Int J Fertil Womens Med; 1997 Jun; 42 Suppl 2():376-87. PubMed ID: 9397385
    [Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of a low-dose maintenance therapy with transdermal estradiol gel in Japanese women with estrogen deficiency symptoms.
    Mizunuma H.
    Climacteric; 2011 Oct; 14(5):581-9. PubMed ID: 21848497
    [Abstract] [Full Text] [Related]

  • 17. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.
    Al-Azzawi F, Buckler HM, United Kingdom Vaginal Ring Investigator Group.
    Climacteric; 2003 Jun; 6(2):118-27. PubMed ID: 12841882
    [Abstract] [Full Text] [Related]

  • 18. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M.
    Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046
    [Abstract] [Full Text] [Related]

  • 19. A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1mg estradiol valerate/2mg dienogest on hot flushes in postmenopausal women.
    Endrikat J, Graeser T, Mellinger U, Ertan K, Holz C.
    Maturitas; 2007 Oct 20; 58(2):201-7. PubMed ID: 17889463
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
    Adler G, Young D, Galant R, Quinn L, Witchger MS, Maki KC.
    Gynecol Obstet Invest; 2005 Oct 20; 59(4):212-9. PubMed ID: 15753617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.